| 摘要 |
Preferred embodiments of the present invention are related to novel therapeutic drug combinations and methods for treating and/or preventing hypertension and complications in patients with diabetes and/or metabolic syndrome. More particularly, aspects of the present invention are related to using a combination of cicletanine and lacidipine (a preferred calcium antagonist) for treating and/or preventing hypertension and complications in patients with diabetes and/or metabolic syndrome.
|
